News

16 July 2009

 

Riber’s first-half sales up 14% on a year ago, driven by research reactors

For first-half 2009, Riber S.A. of Bezons, France, which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells, has reported sales of €5.9m, up 14% on a year ago.

Despite the economic difficulties surrounding the semiconductor industry, system sales remained strong over first-half 2009 compared with last year, the firm says. Growth was driven by sales of MBE systems to research centers: four systems, including the new MPVD300 (a 300mm modular system for high-vacuum deposition that can be connected directly to a silicon production line).

Component and services sales fell back slightly, but Riber says that it offset the impact of the economic crisis in the industry by developing sales associated with installed research reactors, as well as with reactors of the VG brand (acquired in September 2008).

Order backlog is up 17% on a year ago to €6.1m, consisting of seven research systems (for delivery in 2009) as well as higher component and service sales.

Full first-half 2009 results and sales guidance for second-half 2009 will be released on 2 September (after close of trading).

See related items:

Riber returns to operating profit in 2008

Riber grew 13% in 2008, driven by production MBE reactors

Search: Riber MBE

Visit: www.riber.com